Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric L Simpson

Showing results (231-240 of 315) with videos related to

Pageof 32
Sort By:
Dermatitis : Contact, Atopic, Occupational, Drug|July 19, 2016
A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus OpinionJennifer K Chen, Sharon E Jacob, Susan T Nedorost, et al.
The Journal of Investigative Dermatology|November 4, 2018
Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult PopulationZelma C Chiesa Fuxench, Julie K Block, Mark Boguniewicz, et al.
The Journal of Allergy and Clinical Immunology|December 29, 2023
Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis: A phase 2 randomized trial (CBP-201-WW001)Jonathan I Silverberg, Bruce Strober, Brian Feinstein, et al.
Lancet (London, England)|July 27, 2020
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialEric L Simpson, Rodney Sinclair, Seth Forman, et al.
Science Advances|January 6, 2023
Exposure to isocyanates predicts atopic dermatitis prevalence and disrupts therapeutic pathways in commensal bacteriaJordan Zeldin, Prem Prashant Chaudhary, Jacquelyn Spathies, et al.
The British Journal of Dermatology|December 4, 2023
Burden of atopic dermatitis in paediatric patients: an international cross-sectional studyStephan Weidinger, Eric L Simpson, Jonathan I Silverberg, et al.
JAMA Dermatology|July 5, 2018
Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic DermatitisEric L Simpson, Emma Guttman-Yassky, David J Margolis, et al.
JAMA Dermatology|July 23, 2025
Emollients to Prevent Pediatric Eczema: A Randomized Clinical TrialEric L Simpson, LeAnn C Michaels, Katrina Ramsey, et al.
Dermatology and Therapy|February 12, 2026
Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 StudiesAndrew Blauvelt, Leon Kircik, Eric L Simpson, et al.
The British Journal of Dermatology|July 1, 2026
Sustained efficacy of dupilumab in pediatric patients with moderate-to-severe atopic dermatitis over 1 yearElaine C Siegfried, Eulalia Baselga, Marlies de Graaf, et al.
Pageof 32

Showing results (231-240 of 315) with videos related to

Sort By:
Pageof 32
Dermatitis : Contact, Atopic, Occupational, Drug|July 19, 2016
A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus OpinionJennifer K Chen, Sharon E Jacob, Susan T Nedorost, et al.
The Journal of Investigative Dermatology|November 4, 2018
Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult PopulationZelma C Chiesa Fuxench, Julie K Block, Mark Boguniewicz, et al.
The Journal of Allergy and Clinical Immunology|December 29, 2023
Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis: A phase 2 randomized trial (CBP-201-WW001)Jonathan I Silverberg, Bruce Strober, Brian Feinstein, et al.
Lancet (London, England)|July 27, 2020
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialEric L Simpson, Rodney Sinclair, Seth Forman, et al.
Science Advances|January 6, 2023
Exposure to isocyanates predicts atopic dermatitis prevalence and disrupts therapeutic pathways in commensal bacteriaJordan Zeldin, Prem Prashant Chaudhary, Jacquelyn Spathies, et al.
The British Journal of Dermatology|December 4, 2023
Burden of atopic dermatitis in paediatric patients: an international cross-sectional studyStephan Weidinger, Eric L Simpson, Jonathan I Silverberg, et al.
JAMA Dermatology|July 5, 2018
Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic DermatitisEric L Simpson, Emma Guttman-Yassky, David J Margolis, et al.
JAMA Dermatology|July 23, 2025
Emollients to Prevent Pediatric Eczema: A Randomized Clinical TrialEric L Simpson, LeAnn C Michaels, Katrina Ramsey, et al.
Dermatology and Therapy|February 12, 2026
Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 StudiesAndrew Blauvelt, Leon Kircik, Eric L Simpson, et al.
The British Journal of Dermatology|July 1, 2026
Sustained efficacy of dupilumab in pediatric patients with moderate-to-severe atopic dermatitis over 1 yearElaine C Siegfried, Eulalia Baselga, Marlies de Graaf, et al.
Pageof 32